Advertisement
Advertisement

EYPT

EYPT logo

EyePoint, Inc. Common Stock

13.43
USD
Sponsored
-0.19
-1.40%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

13.47

+0.04
+0.34%

EyePoint, Inc. Common Stock Profile

About

EYEPOINT INC is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. EYEPOINT INC, formerly known as EyePoint Pharmaceuticals Inc., is based in WATERTOWN, Mass.

Info & Links

CEO

Jay S. Duker

Headquarters

480 PLEASANT STREET
WATERTOWN, MA 02472, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.eyepointpharma.com

Auditor

Deloitte & Touche LLP

Share holders

33

Employees

214

EyePoint, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.13B

Enterprise Value

1.03B

Enterprise Value/EBITDA(ttm)

-4.18

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

37.84

Price to Book(mrq)

3.85

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

64.60%

Operating Margin(ttm)

-739.39%

Profit Margin(ttm)

-4601.21%

Return on Equity(ttm)

-88.31%

Return on Invested Capital(ttm)

-91.23%

Return on Assets(ttm)

-72.52%

Income Statement

Revenue(ttm)

31.37M

Revenue Per Share(ttm)

0.38

Gross Profit(ttm)

29.30M

EBITDA(ttm)3

-245.95M

Net Income Available to Common(ttm)

-231.96M

Diluted EPS(ttm)

-3.16

Share Statistics

Beta (5Y Monthly)

1.89

52-Week Change

127.24%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

83.43M

Dividend Yield

0.00%

Float4

79.71M

% Held by Insiders

4.46%

% Held by Institutions

99.41%

Balance Sheet

Total Cash(mrq)

306.09M

Total Cash Per Share(mrq)

3.67

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.88%

Quick Ratio(mrq)

8.83%

Book Value Per Share(mrq)

3.70

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.28

Free Cash Flow(ytd)

-243.24M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement